Literature DB >> 35199038

High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry.

Ilaria M Michelozzi1, Jahangir Sufi2, Thomas A Adejumo3, Persis J Amrolia1,4, Christopher J Tape2, Alice Giustacchini1.   

Abstract

Here, we present a comprehensive protocol for the generation and functional characterization of chimeric antigen receptor (CAR) T cells and their products by mass cytometry in a reproducible and scalable manner. We describe the production of CAR T cells from human peripheral blood mononuclear cells. We then detail a three-step staining protocol with metal-labeled antibodies and the subsequent mass cytometry analysis. This protocol allows simultaneous characterization of CAR T cell intracellular signaling, activation, proliferation, cytokine production, and phenotype in a single assay.
© 2022 The Author(s).

Entities:  

Keywords:  Cell Biology; Cell culture; Cell isolation; Flow Cytometry/Mass Cytometry; Health Sciences; Immunology; Single Cell

Mesh:

Substances:

Year:  2022        PMID: 35199038      PMCID: PMC8844283          DOI: 10.1016/j.xpro.2022.101174

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


  19 in total

1.  Acquisition, Processing, and Quality Control of Mass Cytometry Data.

Authors:  Brian H Lee; Adeeb H Rahman
Journal:  Methods Mol Biol       Date:  2019

2.  Automated Data Cleanup for Mass Cytometry.

Authors:  Charles Bruce Bagwell; Margaret Inokuma; Benjamin Hunsberger; Donald Herbert; Christopher Bray; Beth Hill; Gregory Stelzer; Stephen Li; Avinash Kollipara; Olga Ornatsky; Vladimir Baranov
Journal:  Cytometry A       Date:  2019-11-18       Impact factor: 4.355

Review 3.  A guide to manufacturing CAR T cell therapies.

Authors:  Philipp Vormittag; Rebecca Gunn; Sara Ghorashian; Farlan S Veraitch
Journal:  Curr Opin Biotechnol       Date:  2018-02-18       Impact factor: 9.740

4.  Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.

Authors:  Renier J Brentjens; Isabelle Rivière; Jae H Park; Marco L Davila; Xiuyan Wang; Jolanta Stefanski; Clare Taylor; Raymond Yeh; Shirley Bartido; Oriana Borquez-Ojeda; Malgorzata Olszewska; Yvette Bernal; Hollie Pegram; Mark Przybylowski; Daniel Hollyman; Yelena Usachenko; Domenick Pirraglia; James Hosey; Elmer Santos; Elizabeth Halton; Peter Maslak; David Scheinberg; Joseph Jurcic; Mark Heaney; Glenn Heller; Mark Frattini; Michel Sadelain
Journal:  Blood       Date:  2011-08-17       Impact factor: 22.113

5.  Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.

Authors:  Jonathan Fisher; Roshan Sharma; Dilu Wisidagamage Don; Marta Barisa; Marina Olle Hurtado; Pierre Abramowski; Lucy Porter; William Day; Roberto Borea; Sarah Inglott; John Anderson; Dana Pe'er
Journal:  Sci Signal       Date:  2019-09-10       Impact factor: 8.192

6.  Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

Authors:  Sara Ghorashian; Anne Marijn Kramer; Shimobi Onuoha; Gary Wright; Jack Bartram; Rachel Richardson; Sarah J Albon; Joan Casanovas-Company; Fernanda Castro; Bilyana Popova; Krystle Villanueva; Jenny Yeung; Winston Vetharoy; Aleks Guvenel; Patrycja A Wawrzyniecka; Leila Mekkaoui; Gordon Weng-Kit Cheung; Danielle Pinner; Jan Chu; Giovanna Lucchini; Juliana Silva; Oana Ciocarlie; Arina Lazareva; Sarah Inglott; Kimberly C Gilmour; Gulrukh Ahsan; Mathieu Ferrari; Somayya Manzoor; Kim Champion; Tony Brooks; Andre Lopes; Allan Hackshaw; Farzin Farzaneh; Robert Chiesa; Kanchan Rao; Denise Bonney; Sujith Samarasinghe; Nicholas Goulden; Ajay Vora; Paul Veys; Rachael Hough; Robert Wynn; Martin A Pule; Persis J Amrolia
Journal:  Nat Med       Date:  2019-09-02       Impact factor: 53.440

7.  Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.

Authors:  Daniel T MacLeod; Jeyaraj Antony; Aaron J Martin; Rachel J Moser; Armin Hekele; Keith J Wetzel; Audrey E Brown; Melissa A Triggiano; Jo Ann Hux; Christina D Pham; Victor V Bartsevich; Caitlin A Turner; Janel Lape; Samantha Kirkland; Clayton W Beard; Jeff Smith; Matthew L Hirsch; Michael G Nicholson; Derek Jantz; Bruce McCreedy
Journal:  Mol Ther       Date:  2017-02-23       Impact factor: 11.454

8.  Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry.

Authors:  Gaëlle Dzangué-Tchoupou; Aurélien Corneau; Catherine Blanc; Olivier Benveniste; Yves Allenbach
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

9.  Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium.

Authors:  Andrew R Medvec; Christopher Ecker; Hong Kong; Emily A Winters; Joshua Glover; Angel Varela-Rohena; James L Riley
Journal:  Mol Ther Methods Clin Dev       Date:  2017-11-07       Impact factor: 6.698

10.  Development of a Comprehensive Antibody Staining Database Using a Standardized Analytics Pipeline.

Authors:  El-Ad David Amir; Brian Lee; Paul Badoual; Martin Gordon; Xinzheng V Guo; Miriam Merad; Adeeb H Rahman
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.